Company Filing History:
Years Active: 1982-1989
Title: Charles M Kinzig: Innovator in Leukotriene Research
Introduction
Charles M Kinzig is a notable inventor based in Merion Station, PA (US). He has made significant contributions to the field of pharmacology, particularly in the development of leukotriene antagonists. With a total of 4 patents to his name, Kinzig's work has implications for treating various diseases.
Latest Patents
Among his latest patents, Kinzig has developed a method for inhibiting the effects of LTB.sub.4 through the administration of specific compounds. This method is crucial for treating diseases where LTB.sub.4 plays a significant role. Additionally, he has worked on the preparation of esters of leukotriene A, which are useful intermediates in synthesizing naturally occurring leukotrienes known for their potent broncho-constricting properties.
Career Highlights
Kinzig's career has been marked by his association with SmithKline Beckman Corporation, where he has conducted extensive research. His innovative approaches have led to advancements in the understanding and treatment of conditions related to leukotrienes.
Collaborations
Throughout his career, Kinzig has collaborated with esteemed colleagues such as John G Gleason and Deborah Lynne Bryan. These partnerships have fostered a collaborative environment that has enhanced the quality and impact of their research.
Conclusion
Charles M Kinzig's contributions to the field of pharmacology, particularly in leukotriene research, highlight his role as an influential inventor. His patents and collaborative efforts continue to pave the way for advancements in medical treatments.